These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 37857877)

  • 21. Pharmaceutically active compounds: Their removal during slow sand filtration and their impact on slow sand filtration bacterial removal.
    D'Alessio M; Yoneyama B; Kirs M; Kisand V; Ray C
    Sci Total Environ; 2015 Aug; 524-525():124-35. PubMed ID: 25889551
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Removal of pharmaceutically active compounds in nitrifying-denitrifying plants.
    Suárez S; Ramil M; Omil F; Lema JM
    Water Sci Technol; 2005; 52(8):9-14. PubMed ID: 16312946
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Screening and Seasonal Behavior of Analgesics, Non-steroidal Anti-inflammatory Drugs, and Antibiotics in Two Urban Wastewater Treatment Plants.
    Rodrigues JA; Silva S; Cardoso VV; Benoliel MJ; Cardoso E; Coelho MR; Martins A; Almeida CMM
    Environ Manage; 2021 Sep; 68(3):411-425. PubMed ID: 34269831
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Removal of pharmaceutical compounds in water and wastewater using fungal oxidoreductase enzymes.
    Naghdi M; Taheran M; Brar SK; Kermanshahi-Pour A; Verma M; Surampalli RY
    Environ Pollut; 2018 Mar; 234():190-213. PubMed ID: 29175684
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmaceuticals as chemical markers of wastewater contamination in the vulnerable area of the Ebro Delta (Spain).
    Čelić M; Gros M; Farré M; Barceló D; Petrović M
    Sci Total Environ; 2019 Feb; 652():952-963. PubMed ID: 30380500
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of sorption processes in the removal of pharmaceuticals by fungal treatment of wastewater.
    Lucas D; Castellet-Rovira F; Villagrasa M; Badia-Fabregat M; Barceló D; Vicent T; Caminal G; Sarrà M; Rodríguez-Mozaz S
    Sci Total Environ; 2018 Jan; 610-611():1147-1153. PubMed ID: 28847135
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Removal of pharmaceutical active compounds in wastewater by constructed wetlands: Performance and mechanisms.
    Zhang H; Wang XC; Zheng Y; Dzakpasu M
    J Environ Manage; 2023 Jan; 325(Pt A):116478. PubMed ID: 36272291
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictive models for the degradation of 4 pharmaceutically active compounds in municipal wastewater effluents by the UV/H
    Shi Y; Shen G; Geng J; Fu Y; Li S; Wu G; Wang L; Xu K; Ren H
    Chemosphere; 2021 Jan; 263():127944. PubMed ID: 32854006
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Photo-transformation of pharmaceutically active compounds in the aqueous environment: a review.
    Yan S; Song W
    Environ Sci Process Impacts; 2014 Apr; 16(4):697-720. PubMed ID: 24608883
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Occurrence and risk assessment of pharmaceutically active compounds in water supply systems in Brazil.
    Santos AV; Couto CF; Lebron YAR; Moreira VR; Foureaux AFS; Reis EO; Santos LVS; de Andrade LH; Amaral MCS; Lange LC
    Sci Total Environ; 2020 Dec; 746():141011. PubMed ID: 32763601
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pilot-scale removal of pharmaceuticals in municipal wastewater: Comparison of granular and powdered activated carbon treatment at three wastewater treatment plants.
    Kårelid V; Larsson G; Björlenius B
    J Environ Manage; 2017 May; 193():491-502. PubMed ID: 28256364
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Occurence and Prioritization of Pharmaceutical Active Compounds in Domestic/Municipal Wastewater Treatment Plants.
    Vergili I; Kaya Y; Gönder ZB; Boergers A; Tuerk J
    Bull Environ Contam Toxicol; 2019 Feb; 102(2):252-258. PubMed ID: 30666389
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Degradations of endocrine-disrupting chemicals and pharmaceutical compounds in wastewater with carbon-based nanomaterials: a critical review.
    Ojha A; Tiwary D; Oraon R; Singh P
    Environ Sci Pollut Res Int; 2021 Jun; 28(24):30573-30594. PubMed ID: 33909248
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Status of hormones and painkillers in wastewater effluents across several European states-considerations for the EU watch list concerning estradiols and diclofenac.
    Schröder P; Helmreich B; Škrbić B; Carballa M; Papa M; Pastore C; Emre Z; Oehmen A; Langenhoff A; Molinos M; Dvarioniene J; Huber C; Tsagarakis KP; Martinez-Lopez E; Pagano SM; Vogelsang C; Mascolo G
    Environ Sci Pollut Res Int; 2016 Jul; 23(13):12835-66. PubMed ID: 27023823
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Study of a large scale powdered activated carbon pilot: Removals of a wide range of emerging and priority micropollutants from wastewater treatment plant effluents.
    Mailler R; Gasperi J; Coquet Y; Deshayes S; Zedek S; Cren-Olivé C; Cartiser N; Eudes V; Bressy A; Caupos E; Moilleron R; Chebbo G; Rocher V
    Water Res; 2015 Apr; 72():315-30. PubMed ID: 25466636
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nano-adsorbents an effective candidate for removal of toxic pharmaceutical compounds from aqueous environment: A critical review on emerging trends.
    Neha R; Adithya S; Jayaraman RS; Gopinath KP; M P; L P; Arun J
    Chemosphere; 2021 Jun; 272():129852. PubMed ID: 33581563
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Occurrence, fate and removal of pharmaceuticals, personal care products and pesticides in wastewater stabilization ponds and receiving rivers in the Nzoia Basin, Kenya.
    K'oreje KO; Kandie FJ; Vergeynst L; Abira MA; Van Langenhove H; Okoth M; Demeestere K
    Sci Total Environ; 2018 Oct; 637-638():336-348. PubMed ID: 29751313
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SU-101 for the removal of pharmaceutical active compounds by the combination of adsorption/photocatalytic processes.
    Chacón-García AJ; Rojas S; Grape ES; Salles F; Willhammar T; Inge AK; Pérez Y; Horcajada P
    Sci Rep; 2024 Apr; 14(1):7882. PubMed ID: 38570568
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Microbial community response during the treatment of pharmaceutically active compounds (PhACs) in constructed wetland mesocosms.
    Yan Q; Min J; Yu Y; Zhu Z; Feng G
    Chemosphere; 2017 Nov; 186():823-831. PubMed ID: 28826130
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fate and distribution of pharmaceutically active compounds in mesocosm constructed wetlands.
    He Y; Sutton NB; Lei Y; Rijnaarts HHM; Langenhoff AAM
    J Hazard Mater; 2018 Sep; 357():198-206. PubMed ID: 29886365
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.